Osteoblast maturation suppressed osteoclastogenesis in coculture with bone marrow cells

Biochemical and Biophysical Research Communications

Volumn 274, Issue 1, 2000, Pages 249-254

  Deyama, Yoshiaki ^a   Takeyama, Sadaaki ^a   Koshikawa, Mino ^a   Shirai, Yoichi ^a   Yoshimura, Yoshitaka ^a   Nishikata, Makoto ^a   Suzuki, Kuniaki ^a   Matsumoto, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Co culture system; M CSF CSF 1; ODF RANKL; OPG OCIF; Osteoblast maturation; Osteoclastogenesis

Indexed keywords

COLONY STIMULATING FACTOR 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN SECRETION; TRANSCRIPTION REGULATION;

EID: 0033916128     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3127     Document Type: Article

References (24)

1. Takahashi N., Akatsu T., Udagawa N., Sasaki T., Yamaguchi A., Moseley J. M., Martin T. J., Suda T. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123:1988;2600-2602.
2. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Koishihara Y., Ohsugi Y., Kumaki K., Taga T., Kishimoto T., Suda T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc. Natl. Acad. Sci. USA. 90:1993;11924-11928.
3. Udagawa N., Takahashi N., Akitsu T., Sasaki T., Yamaguchi A., Kodama H., Martin T. J., Suda T. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1989;1805-1813.
4. Udagawa N., Takahashi N., Akitsu T., Tanaka T., Sasaki T., Nishihara T., Koga T., Martin T. J., Suda T. Origin of osteoclast: mature monocytes and macropharges are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA. 87:1990;7260-7264.
5. Hofbauer L. C., Lacey D. L., Dunstan C. R., Spelsberg T. C., Riggs B. L., Khosla S. Interleukin-1β and Tumor Necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone. 25:1999;255-259.
6. Jimi E., Nakamura I., Amano H., Taguchi Y., Tsurukai T., Tamura M., Takahashi N., Suda T. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology. 137:1996;2187-2190.
7. Lacey D. L., Timms E., Tan H. L., Kelley M. J., Dunstan C. R., Burgess T., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Quian Y. X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
8. Matsuzaki K., Udagawa N., Takahashi N., Yamaguchi K., Yasuda H., Shima N., Morinaga T., Toyama Y., Yabe Y., Higashio K., Suda T. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem. Biophys. Res. Commun. 246:1998;199-204.
9. Quinn J. W. M., Elliott J., Gillespie M. T., Martin T. J. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology. 139:1998;4424-4427.
10. Wiktor-Jedrzejczak W., Bartoccim A., Ferrante A. W. Jr., Ahmed-Ansari A., Sell K. W., Pollard J. W., Stanley E. R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA. 87:1990;4828-4832.
11. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L. D., Nishikawa S. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:1990;442-444.
12. Owen T. A, Aronow M., Shalhoub V., Barone L. M., Wilming L., Tassinri M. S., Kennedy M. B., Pockwines S., Lian J. B., Stein G. S. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationship in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143:1990;420-430.
13. Shirai Y., Yoshimura Y., Yawaka Y., Hasegawa T., Kikuiri T., Takeyama S., Matsumoto A., Oguchi H. Effect of extracellular calcium concentrations on osteoclast differntiation in vivo. Biochem. Biophys. Res. Commun. 265:1999;484-488.
14. Kartsogiannis V., Zhou H., Horwood N. J., Thomas R. J., Hards D. K., Quinn J. M., Niforas P., NG K. W., Martin T. J., Gillespie M. T. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone. 25:1999;525-534.
15. Suda T., Jimi E., Nakamura I., Takahashi N. Role of 1α,25-dihydroxyvitamine D3 in osteoclast differentiation and function. Methods Enzymol. 282:1997;223-235.
16. Suzuki K., Yoshimura Y., Hisada Y., Matsumoto A. Sensitivity of intestinal alkaline phosphatase to L-homoarginine and its regulation by subunit-subunit interaction. Jpn. J. Pharmacol. 64:1994;97-102.
17. Bessey O. A., Lowry O. H., Brock M. J. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J. Biol. Chem. 164:1946;321-329.
18. Dignam J. D., Lebowitz R. M., Roeder R. G. Accurate transcription by RNA polymerase II in soluble extracts from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
19. Schreiber E., Matthias P., Muller M. M., Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
20. Deyama A., Deyama Y., Matsumoto A., Yoshimura Y., Nishikata M., Suzuki K., Totsuka Y. A low calcium environment enhances AP-1 transcription factor-mediated gene expression in the development of osteoblastic MC3T3-E1 cells. Miner. Electrolyte Metab. 25:1999;147-160.
21. Simonet W. S., Lacey D. L., Dunstan C. R., Kelley M., Chang M. S., Luthy R., Nguyen H. Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H. L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T. M., Hill D., Pattison W., Campbell P., Boyle W. J. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 89:1997;309-319.
22. Yasuda H., Shima N., Nakagawa N., Mochizuki S. I., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., Kanno T., Murakami A., Tsuda E., Morinaga T., Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 139:1998;1329-1337.
23. Kodama H., Yamasaki A., Nose M., Niida S., Ohgame Y., Abe M., Kumegawa M., Suda T. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J. Exp. Med. 17:1991;269-272.
24. Felix R., Cecchini M. G., Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology. 127:1990;2592-2594.